FETUB and metabolic dysfunction-associated steatotic liver disease: Nonetheless, as regards fetuin-B and NAFLD, the following clinical characteristics had a negative effect on SMD: BMI (β BMI = −0.0374, SE = 0.1057, p = 0.747), age (β age = −0.0236, SE = 0.0316, p = 0.509), ALT (β ALT = −0.0080, SE = 0.0069, p = 0.331), AST (β AST = −0.0056, SE = 0.0058, p = 0.406), GGT (β GGT = −0.007, SE = 0.0007, p = 0.406), LDL (β LDL = −0.1100, SE = 0.1519, p = 0.544) and HDL (β HDL = −0.3586, SE = 0.4076, p = 0.472).